Clinical review: A review and analysis of heart rate variability and the diagnosis and prognosis of infection

Critical Care

Volumn 13, Issue 6, 2009, Pages

  Ahmad, Saif ^a   Tejuja, Anjali ^a   Newman, Kimberley D ^a   Zarychanski, Ryan ^b,c   Seely, Andrew J E ^a,d  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c CancerCare Manitoba ^*  (Canada)

^d UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC THERAPY; CRITICALLY ILL PATIENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE SEVERITY; HEART RATE VARIABILITY; HUMAN; INFECTION; NEWBORN SEPSIS; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SEPSIS; BACTERIAL INFECTION; CRITICAL ILLNESS; HEART RATE; METHODOLOGY; MORTALITY; OBSERVER VARIATION; PATHOPHYSIOLOGY; PHYSIOLOGY; RESUSCITATION;

BACTERIAL INFECTIONS; CRITICAL ILLNESS; HEART RATE; HUMANS; OBSERVER VARIATION; PROGNOSIS; RESUSCITATION;

EID: 77951639132     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc8132     Document Type: Review

References (64)

1. Brun-Buisson C. The epidemiology of the systemic inflammatory response. Intensive Care Med 2000, 26(Suppl 1):S64-74. 10786961, 10.1007/s001340051121.
2. Marik PE, Varon J. Sepsis: state of the art. Dis Mon 2001, 47:465-532. 11641650, 10.1067/mda.2001.119745.
3. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001, 29:1303-1310. 11445675, 10.1097/00003246-200107000-00002.
4. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992, 101:1644-1655. 1303622, 10.1378/chest.101.6.1644.
5. Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, Suppes R, Feinstein D, Zanotti S, Taiberg L, Gurka D, Kumar A, Cheang M. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006, 34:1589-1596. 16625125, 10.1097/01.CCM.0000217961.75225.E9.
6. Rivers EP, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M, . Early Goal-Directed Therapy Collaborative Group Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Eng J Med 2001, 345:1368-1377. 11794169, 10.1056/NEJMoa010307, Early Goal-Directed Therapy Collaborative Group.
7. Otero RM, Nguyen HB, Huang DT, Gaieski DF, Goyal M, Gunnerson KJ, Trzeciak S, Sherwin R, Holthaus CV, Osborn T, Rivers EP. Early goal-directed therapy in severe sepsis and septic shock revisited: concepts, controversies, and contemporary findings. Chest 2006, 130:1579-1595. 17099041, 10.1378/chest.130.5.1579.
8. Brunkhorst FM, Wegscheider K, Forycki ZF, Brunkhorst R. Pro-calcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis, and septic shock. Intensive Care Med 2000, 26(Suppl 2):S148-152.
9. Castelli GP, Pognani C, Cita M, Stuani A, Sgarbi L, Paladini R. Procalcitonin, C-reactive protein, white blood cells and SOFA score in ICU: diagnosis and monitoring of sepsis. Minerva Anestesiol 2006, 72:69-80.
10. Endo S, Aikawa N, Fujishima S, Sekine I, Kogawa K, Yamamoto Y, Kushimoto S, Yukioka H, Kato N, Totsuka K, Kikuchi K, Ikeda T, Ikeda K, Yamada H, Harada K, Satomura S. Usefulness of pro-calcitonin serum level for the discrimination of severe sepsis from sepsis: a multicenter prospective study. J Infect Chemother 2008, 14:244-249. 18574663, 10.1007/s10156-008-0608-1.
11. Jensen JU, Lundgren B, Hein L, Mohr T, Petersen PL, Andersen LH, Lauritsen AO, Hougaard S, Mantoni T, Bømler B, Thornberg KJ, Thormar K, Løken J, Steensen M, Carl P, Petersen JA, Tousi H, Søe-Jensen P, Bestle M, Hestad S, Andersen MH, Fjeldborg P, Larsen KM, Rossau C, Thomsen CB, Ostergaard C, Kjaer J, Grarup J, Lundgren JD. The Procalcitonin And Survival Study (PASS) - a randomised multi-center investigator-initiated trial to investigate whether daily measurements biomarker Procalcitonin and pro-active diagnostic and therapeutic responses to abnormal Procalcitonin levels, can improve survival in intensive care unit patients. Calculated sample size (target population): 1000 patients. BMC Infect Dis 2008, 8:91. 18620598, 10.1186/1471-2334-8-91, 2491622.
12. Kandil E, Burack J, Sawas A, Bibawy H, Schwartzman A, Zenilman ME, Bluth MH. B-type natriuretic peptide: a biomarker for the diagnosis and risk stratification of patients with septic shock. Arch Surg 2008, 143:242-246. discussion 246, 18347270, 10.1001/archsurg.2007.69.
13. Larosa SP, Opal SM. Sepsis strategies in development. Clin Chest Med 2008, 29:735-747. 18954707, 10.1016/j.ccm.2008.06.007.
14. Liaw PC. Endogenous protein C activation in patients with severe sepsis. Crit Care Med 2004, 32(5 Suppl):S214-218. 15118520, 10.1097/01.CCM.0000126125.79861.D3.
15. McLean AS, Huang SJ. The applications of B-type natriuretic peptide measurement in the intensive care unit. Curr Opin Crit Care 2005, 11:406-412. 16175025, 10.1097/01.ccx.0000176695.92883.87.
16. Mesters RM, Helterbrand J, Utterback BG, Yan B, Chao YB, Fernandez JA, Griffin JH, Hartman DL. Prognostic value of protein C concentrations in neutropenic patients at high risk of severe septic complications. Crit Care Med 2000, 28:2209-2216. 10921542, 10.1097/00003246-200007000-00005.
17. Pramod J, Singh A. Sepsis biomarkers. Am J Med 2008, 121:e11. author reply e13, 18501208, 10.1016/j.amjmed.2007.12.009.
18. Sandri MT, Passerini R, Leon ME, Peccatori FA, Zorzino L, Salvatici M, Riggio D, Cassatella C, Cinieri S, Martinelli G. Procalcitonin as a useful marker of infection in hematooncological patients with fever. Anticancer Res 2008, 28:3061-3065.
19. Simon L, Saint-Louis P, Amre DK, Lacroix J, Gauvin F. Procalcitonin and C-reactive protein as markers of bacterial infection in critically ill children at onset of systemic inflammatory response syndrome. Pediatr Crit Care Med 2008, 9:407-413. 18496408, 10.1097/PCC.0b013e31817285a6.
20. Holzheimer RG. Antibiotic induced endotoxin release and clinical sepsis: a review. J Chemother 2001, 13(Spec No 1):159-172.
21. Liaw PC, Esmon CT, Kahnamoui K, Schmidt S, Kahnamoui S, Ferrell G, Beaudin S, Julian JA, Weitz JI, Crowther M, Loeb M, Cook D. Patients with severe sepsis vary markedly in their ability to generate activated protein C. Blood 2004, 104:3958-3964. 15319291, 10.1182/blood-2004-03-1203.
22. Seely AJE, Christou NV. Multiple organ dysfunction syndrome: exploring the paradigm of complex nonlinear systems. Crit Care Med 2000, 28:2193-2200. 10921540, 10.1097/00003246-200007000-00003.
23. Seely AJE, Macklem PT. Complex systems and the technology of variability analysis. Crit Care 2004, 8:R367-R384. 15566580, 10.1186/cc2948, 1065053.
24. Stein PK, Kleiger RE. Insights from the study of heart rate variability. Annu Rev Med 1999, 50:249-261. 10073276, 10.1146/annurev.med.50.1.249.
25. Triedman JK, Cohen RJ, Saul JP. Mild hypovolemic stress alters autonomic modulation of heart rate. Hypertension 1993, 21:236-247.
26. Guzzetti S, Mezzetti S, Magatelli R, Porta A, De Angelis G, Rovelli G, Malliani A. Linear and non-linear 24 h heart rate variability in chronic heart failure. Auton Neurosci 2000, 86:114-119. 11269916, 10.1016/S1566-0702(00)00239-3.
27. Borne P, Montano N, Pagani M, Oren R, Somers VK. Absence of low-frequency variability of sympathetic nerve activity in severe heart failure. Circulation 1997, 95:1449-1454.
28. Bonaduce D, Petretta M, Marciano F, Vicario ML, Apicella C, Rao MA, Nicolai E, Volpe M. Independent and incremental prognostic value of heart rate variability in patients with chronic heart failure. Am Heart J 1999, 138:273-284. 10426839, 10.1016/S0002-8703(99)70112-2.
29. Guzzetti S, Piccaluga E, Casati R, Cerutti S, Lombardi F, Pagani M, Malliani A. Sympathetic predominance in essential hypertension: a study employing spectral analysis of heart rate variability. J Hypertens 1988, 6:711-717. 3183374, 10.1097/00004872-198809000-00004.
30. Mussalo H, Vanninen E, Ikaheimo R, Laitinen T, Laakso M, Lansimies E, Hartikainen J. Heart rate variability and its determinants in patients with severe or mild essential hypertension. Clin Physiol 2001, 21:594-604. 11576161, 10.1046/j.1365-2281.2001.00359.x.
31. van Boven AJ, Jukema JW, Haaksma J, Zwinderman AH, Crijns HJ, Lie KI. Depressed heart rate variability is associated with events in patients with stable coronary artery disease and preserved left ventricular function. REGRESS Study Group. Am Heart J 1998, 135:571-576. 9539469, 10.1016/S0002-8703(98)70269-8.
32. Pardo Y, Merz CN, Paul-Labrador M, Velasquez I, Gottdiener JS, Kop WJ, Krantz DS, Rozanski A, Klein J, Peter T. Heart rate variability reproducibility and stability using commercially available equipment in coronary artery disease with daily life myocardial ischemia. Am J Cardiol 1996, 78:866-870. 8888656, 10.1016/S0002-9149(96)00458-4.
33. Huang J, Sopher SM, Leatham E, Redwood S, Camm AJ, Kaski JC. Heart rate variability depression in patients with unstable angina. Am Heart J 1995, 130:772-779. 7572585, 10.1016/0002-8703(95)90076-4.
34. Poulsen SH, Jensen SE, Moller JE, Egstrup K. Prognostic value of left ventricular diastolic function and association with heart rate variability after a first acute myocardial infarction. Heart 2001, 86:376-380. 11559672, 10.1136/heart.86.4.376, 1729921.
35. Kleiger RE, Stein PK, Bosner MS, Rottman JN. Time domain measurements of heart rate variability. Cardiol Clin 1992, 10:487-498.
36. Stein PK. Assessing heart rate variability from real-world Holter reports. Card Electrophysiol Rev 2002, 6:239-244. 12114845, 10.1023/A:1016376924850.
37. Malik M. Heart rate variability - standards of measurement, physiological interpretation, and clinical use. Circulation 1996, 93:1043-1065.
38. Pichot V, Buffiere S, Gaspoz JM, Costes F, Molliex S, Duverney D, Roche F, Barthelemy JC. Wavelet transform of heart rate variability to assess autonomic nervous system activity does not predict arousal from general anesthesia. Can J Anaesth 2001, 48:859-863. 11606341, 10.1007/BF03017350.
39. Thurner SFM, Teich MC. Multiresolution wavelet analysis of heartbeat intervals discriminates healthy patients from those with cardiac pathology. Phys Rev Lett 1998, 80:1544-1547.
40. Pincus SM, Goldberger AL. Physiological time-series analysis: what does regularity quantify?. Am J Physiol 1994, 266:H1643-1656.
41. Engoren M. Approximate entropy of respiratory rate and tidal volume during weaning from mechanical ventilation. Crit Care Med 1998, 26:1817-1823.
42. Costa M, Goldberger AL, Peng CK. Multiscale entropy analysis of biological signals. Phys Rev E Stat Nonlin Soft Matters Phys 2005, 71:021906. 15783351, 10.1103/PhysRevE.71.021906.
43. Peng CK, Buldyrev SV, Havlin S, Simons M, Stanley HE, Goldberger AL. Mosaic organization of DNA nucleotides. Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics 1994, 49:1685-1689. 9961383, 10.1103/PhysRevE.49.1685.
44. Griffin MP, Lake DE, Moorman JR. Heart rate characteristics and laboratory tests in neonatal sepsis. Pediatrics 2005, 115:937-941. 15805367, 10.1542/peds.2004-1393.
45. Griffin MP, Moorman JR. Toward the early diagnosis of neonatal sepsis and sepsis-like illness using novel heart rate analysis. Pediatrics 2001, 107:97-104. 11134441, 10.1542/peds.107.1.97.
46. Moorman JR, Lake DE, Griffin MP. Heart rate characteristics monitoring for neonatal sepsis. IEEE Trans Biomed Eng 2006, 53:126-132. 16402612, 10.1109/TBME.2005.859810.
47. Griffin MP, O'Shea TM, Bissonette EA, Harrell FE, Lake DE, Moorman JR. Abnormal heart rate characteristics preceding neonatal sepsis and sepsis-like illness. Pediatr Res 2003, 53:920-926. 12646726, 10.1203/01.PDR.0000064904.05313.D2.
48. Griffin MP, O'Shea TM, Bissonette EA, Harrell FE, Lake DE, Moorman JR. Abnormal heart rate characteristics are associated with neonatal mortality. Pediatr Res 2004, 55:782-788. 14739356, 10.1203/01.PDR.0000119366.21770.9E.
49. Griffin MP, Lake DE, Bissonette EA, Harrell FE, O'Shea TM, Moorman JR. Heart rate characteristics: novel physiomarkers to predict neonatal infection and death. Pediatrics 2005, 116:1070-1074. 16263991, 10.1542/peds.2004-2461.
50. Cao H, Lake DE, Griffin MP, Moorman JR. Increased nonstationarity of neonatal heart rate before the clinical diagnosis of sepsis. Ann Biomed Eng 2004, 32:233-244. 15008371, 10.1023/B:ABME.0000012743.81754.0b.
51. Kovatchev BP, Farhy LS, Cao H, Griffin MP, Lake DE, Moorman JR. Sample asymmetry analysis of heart rate characteristics with application to neonatal sepsis and systemic inflammatory response syndrome. Pediatr Res 2003, 54:892-898. 12930915, 10.1203/01.PDR.0000088074.97781.4F.
52. Lake DE, Richman JS, Griffin MP, Moorman JR. Sample entropy analysis of neonatal heart rate variability. Am J Physiol Regul Integr Comp Physiol 2002, 283:789-797. 12185014.
53. Ahmad S, Ramsay T, Huebsch L, Flanagan S, McDiarmid S, Batkin I, McIntyre L, Sundaresan SR, Maziak DE, Shamji FM, Hebert P, Fergusson D, Tinmouth A, Seely AJ. Continuous multi-parameter heart rate variability analysis heralds onset of sepsis in adults. PLoS One 2009, 4:e6642. 19680545, 10.1371/journal.pone.0006642, 2721415.
54. Schmidt HB, Werdan K, Muller-Werdan U. Autonomic dysfunction in the ICU patient. Curr Opin Crit Care 2001, 7:314-322. 11805528, 10.1097/00075198-200110000-00002.
55. Yien HW, Hseu SS, Lee LC, Kuo TB, Lee TY, Chan SH. Spectral analysis of systemic arterial pressure and heart rate signals as a prognostic tool for the prediction of patient outcome in the intensive care unit. Crit Care Med 1997, 25:258-266. 9034261, 10.1097/00003246-199702000-00011.
56. Soriano F, Nogueria A, Cappi S, Lins M, Hoshino W, Gonzaga L. Heart dysfunction and heart rate variablility prognoses in sepsis. Crit Care 2004, 8(Suppl 1):P75.
57. Piepoli M, Garrard CS, Kontoyannis DA, Bernardi L. Autonomic control of the heart and peripheral vessels in human septic shock. Intensive Care Med 1995, 21:112-119. 7775691, 10.1007/BF01726532.
58. Pontet J, Contreras P, Curbelo A, Medina J, Noveri S, Bentancourt S, Migliaro ER. Heart rate variability as early marker of multiple organ dysfunction syndrome in septic patients. J Crit Care 2003, 18:156-163. 14595568, 10.1016/j.jcrc.2003.08.005.
59. Annane D, Trabold F, Sharshar T, Jarrin I, Blanc AS, Raphael JC, Gajdos P. Inappropriate sympathetic activation at onset of septic shock: a spectral analysis approach. Am J Respir Crit Care Med 1999, 160:458-465.
60. Barnaby D, Ferrick K, Kaplan DT, Shah S, Bijur P, Gallagher EJ. Heart rate variability in emergency department patients with sepsis. Acad Emerg Med 2002, 9:661-670. 12093705, 10.1111/j.1553-2712.2002.tb02143.x.
61. Garrard CS, Kontoyannis DA, Piepoli M. Spectral analysis of heart rate variability in the sepsis syndrome. Clin Auton Res 1993, 3:5-13. 8386574, 10.1007/BF01819137.
62. Korach M, Sharshar T, Jarrin I, Fouillot JP, Raphael JC, Gajdos P, Annane D. Cardiac variability in critically ill adults: influence of sepsis. Crit Care Med 2001, 29:1380-1385. 11445691, 10.1097/00003246-200107000-00013.
63. Chen WL, Kuo CD. Characteristics of heart rate variability can predict impending septic shock in emergency department patients with sepsis. Acad Emerg Med 2007, 14:392-397.
64. Goldstein B. Heart rate characteristics in neonatal sepsis: a promising test that is still premature. Pediatrics 2005, 115:1070-1072. 15805385, 10.1542/peds.2005-0182.